Back
CBS PREMIUM ACCESS

Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis

Session: Poster session 2
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Speaker: Ms D. Li (Beijing, CN)
Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

Like

About the speaker

Ms Dandan Li

Chinese PLA General Hospital, Beijing (China)
0 follower

72 more presentations in this session

Characterization of senescence in human cardiac fibroblasts

Speaker: Doctor A. Costa (Genoa, IT)

Access
Abstract
Like
Thumbnail

Cardioprotective effect of cemtirestat treatment in male Zucker diabetic fatty rats: a pilot study.

Speaker: Doctor T. Egan Benova (Bratislava, SK)

Access
Abstract
Like
Thumbnail

Dynamic links between the cardiac intermediate filaments of the cytoskeleton and nucleoskeleton for proper cardiomyocyte differentiation, maturation and reprogramming.

Speaker: Doctor M. Tsikitis (Athens, GR)

Access
Abstract
Like
Thumbnail

Differential sex-dependent role of lncRNAs in cardiomyopathy

Speaker: Professor D. Franco (Jaen, ES)

Access
Abstract
Like
Thumbnail

MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques.

Speaker: Mr J. Koester (Halle, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 2

Speakers: Ms D. Li, Doctor A. Costa, Doctor T. Egan Benova, Doctor M. Tsikitis, Professor D. Franco...
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources